Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gammaitoni

Showing results (41-50 of 230) with videos related to

Pageof 23
Sort By:
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|November 29, 2002
Pharmacokinetics and safety of continuously applied lidocaine patches 5%Arnold R Gammaitoni, Nancy A Alvarez, Bradley S Galer
Journal of Clinical Pharmacology|March 6, 2003
Safety and tolerability of the lidocaine patch 5%, a targeted peripheral analgesic: a review of the literatureArnold R Gammaitoni, Nancy A Alvarez, Bradley S Galer
Current Gene Therapy|December 25, 2013
Genetically redirected T lymphocytes for adoptive immunotherapy of solid tumorsValeria Leuci, Giulia Mesiano, Loretta Gammaitoni, et al.
Journal of Clinical Pharmacology|February 11, 2005
Oxymorphone extended release does not affect CYP2C9 or CYP3A4 metabolic pathwaysMichael Adams, Henry J Pieniaszek, Arnold R Gammaitoni, et al.
Pharmacotherapy|January 1, 1993
Propafenone-theophylline interactionS A Spinler, A Gammaitoni, S L Charland, et al.
Oncoimmunology|July 23, 2014
Activity of cytokine-induced killer cells against bone and soft tissue sarcomaDario Sangiolo, Giulia Mesiano, Loretta Gammaitoni, et al.
Scientific Reports|October 26, 2018
Vogel-Fulcher-Tamman criticality of 3D superinsulatorsM C Diamantini, L Gammaitoni, C A Trugenberger, et al.
Medgenmed : Medscape General Medicine|April 5, 2007
A comparison of the lidocaine patch 5% vs naproxen 500 mg twice daily for the relief of pain associated with carpal tunnel syndrome: a 6-week, randomized, parallel-group studySrinivas Nalamachu, R S Crockett, Arnold R Gammaitoni, et al.
Pain Medicine (Malden, Mass.)|July 23, 2003
Effectiveness and safety of new oxycodone/acetaminophen formulations with reduced acetaminophen for the treatment of low back painArnold R Gammaitoni, Bradley S Galer, Peter Lacouture, et al.
The Clinical Journal of Pain|September 11, 2003
Clinical application of opioid equianalgesic dataArnold R Gammaitoni, Perry Fine, Nancy Alvarez, et al.
Pageof 23

Showing results (41-50 of 230) with videos related to

Sort By:
Pageof 23
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|November 29, 2002
Pharmacokinetics and safety of continuously applied lidocaine patches 5%Arnold R Gammaitoni, Nancy A Alvarez, Bradley S Galer
Journal of Clinical Pharmacology|March 6, 2003
Safety and tolerability of the lidocaine patch 5%, a targeted peripheral analgesic: a review of the literatureArnold R Gammaitoni, Nancy A Alvarez, Bradley S Galer
Current Gene Therapy|December 25, 2013
Genetically redirected T lymphocytes for adoptive immunotherapy of solid tumorsValeria Leuci, Giulia Mesiano, Loretta Gammaitoni, et al.
Journal of Clinical Pharmacology|February 11, 2005
Oxymorphone extended release does not affect CYP2C9 or CYP3A4 metabolic pathwaysMichael Adams, Henry J Pieniaszek, Arnold R Gammaitoni, et al.
Pharmacotherapy|January 1, 1993
Propafenone-theophylline interactionS A Spinler, A Gammaitoni, S L Charland, et al.
Oncoimmunology|July 23, 2014
Activity of cytokine-induced killer cells against bone and soft tissue sarcomaDario Sangiolo, Giulia Mesiano, Loretta Gammaitoni, et al.
Scientific Reports|October 26, 2018
Vogel-Fulcher-Tamman criticality of 3D superinsulatorsM C Diamantini, L Gammaitoni, C A Trugenberger, et al.
Medgenmed : Medscape General Medicine|April 5, 2007
A comparison of the lidocaine patch 5% vs naproxen 500 mg twice daily for the relief of pain associated with carpal tunnel syndrome: a 6-week, randomized, parallel-group studySrinivas Nalamachu, R S Crockett, Arnold R Gammaitoni, et al.
Pain Medicine (Malden, Mass.)|July 23, 2003
Effectiveness and safety of new oxycodone/acetaminophen formulations with reduced acetaminophen for the treatment of low back painArnold R Gammaitoni, Bradley S Galer, Peter Lacouture, et al.
The Clinical Journal of Pain|September 11, 2003
Clinical application of opioid equianalgesic dataArnold R Gammaitoni, Perry Fine, Nancy Alvarez, et al.
Pageof 23